Glaukos Corp Stock Today
| GKOS Stock | USD 107.61 5.35 5.23% |
PerformanceVery Weak
| Odds Of DistressLow
|
Glaukos Corp is selling for under 107.61 as of the 24th of March 2025; that is 5.23% increase since the beginning of the trading day. The stock's lowest day price was 104.73. Glaukos Corp has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 24th of December 2024 and ending today, the 24th of March 2025. Click here to learn more.
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California. The company has 56.57 M outstanding shares of which 3.54 M shares are currently shorted by private and institutional investors with about 4.24 trading days to cover. More on Glaukos Corp
Moving together with Glaukos Stock
| 0.64 | HOLX | Hologic | PairCorr |
| 0.72 | INFU | InfuSystems Holdings | PairCorr |
| 0.64 | MLSS | Milestone Scientific Earnings Call This Week | PairCorr |
Moving against Glaukos Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Glaukos Stock Highlights
Glaukos Corp (GKOS) is traded on New York Stock Exchange in USA. It is located in One Glaukos Way, Aliso Viejo, CA, United States, 92656 and employs 995 people. Glaukos Corp is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.78 B. Glaukos Corp conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 56.57 M outstanding shares of which 3.54 M shares are currently shorted by private and institutional investors with about 4.24 trading days to cover.
Glaukos Corp currently holds about 391.19 M in cash with (61.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.22.
Check Glaukos Corp Probability Of Bankruptcy
Ownership AllocationThe majority of Glaukos Corp outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Glaukos Corp to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Glaukos Corp. Please pay attention to any change in the institutional holdings of Glaukos Corp as this could imply that something significant has changed or is about to change at the company.
Check Glaukos Ownership Details
Glaukos Corp Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Glaukos Corp market risk premium is the additional return an investor will receive from holding Glaukos Corp long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (0.50) | |||
| Total Risk Alpha | (0.33) | |||
| Treynor Ratio | 2.18 |
Glaukos Stock Against Markets
Glaukos Corp Corporate Directors
| Gilbert Kliman | Independent Director | Profile | |
| Mark Foley | Lead Independent Director | Profile | |
| Aimee Weisner | Independent Director | Profile | |
| David Hoffmeister | Independent Director | Profile |
Additional Tools for Glaukos Stock Analysis
When running Glaukos Corp's price analysis, check to measure Glaukos Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaukos Corp is operating at the current time. Most of Glaukos Corp's value examination focuses on studying past and present price action to predict the probability of Glaukos Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glaukos Corp's price. Additionally, you may evaluate how the addition of Glaukos Corp to your portfolios can decrease your overall portfolio volatility.